The company’s Purion process retains the amniotic growth factors and cytokines inherent in placental tissue, which creates an Injectable tissue for reducing inflammation and enhancing soft tissue healing.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Implants:
Hospital for Special Surgery Research Analyzes Hip Implant Failures
Wright Medical Group Receives FDA Clearance for Patient-Specific Total Ankle Replacement
43 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in January
MiMedx Group Launches AmnioFix Injectable Allograft
MiMedx Group has launched its AmnioFix Injectable, an allograft composed of micronized amniotic tissue, according to a company news release.
Population health under pressure: What leaders from 3 regions are doing differently
Recommended Whitepaper